RxDoctor Payments Data

Nabil Aboukhair

Gynecology · Cleburne, TXNPI 1508819509

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (56.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 65.1% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $4,743, more than ten times the $334 reported in 2019. Among gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,169in general payments, 2019–2025

Across 156 payments — averaging $45.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • AbbVie$871
  • Exeltis, USA Inc.$145
  • Mayne Pharma Commercial LLC$138
  • Currax Pharmaceuticals LLC$130
  • Braintree Laboratories, Inc.$118
  • plus $1K from 28 others

What the payments were for

  • Speaking & faculty fees$5007%
  • Food & beverage$2,53435%
  • Education$4,01656%
  • Gifts$1182%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,169 in reported general payments places this provider in the 90th percentile of 161 gynecology providers in Texas.

See all gynecology providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImvexxyEstradiol28$5,554
Estradiol21$312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Therapeuticsmd, Inc.Imvexxy$79$5,55428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 161 gynecology providers in Texas.

Other gynecology in Cleburne

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →